These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 670699)

  • 21. Human lymphocytes bear membrane receptors for C3b and C3d.
    Eden A; Miller GW; Nussenzweig V
    J Clin Invest; 1973 Dec; 52(12):3239-42. PubMed ID: 4543024
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Surface markers of complement receptor lymphocytes.
    Ross GD; Winchester RJ; Rabellino EM; Hoffman T
    J Clin Invest; 1978 Nov; 62(5):1086-92. PubMed ID: 711854
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A new activity of complement component C3: cell-bound C3b potentiates lysis of erythrocytes by C5b,6 and terminal components.
    Hammer CH; Abramovitz AS; Mayer MM
    J Immunol; 1976 Sep; 117(3):830-4. PubMed ID: 956655
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Marginal zone B cells express CR1 and CR2 receptors.
    Gray D; McConnell I; Kumararatne DS; MacLennan IC; Humphrey JH; Bazin H
    Eur J Immunol; 1984 Jan; 14(1):47-52. PubMed ID: 6198183
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Native C3 does not bind to the C3b receptor (CR1) of human blood B lymphocytes or alter immunoglobulin synthesis.
    Berger M; Fleisher TA
    J Immunol; 1983 Mar; 130(3):1021-3. PubMed ID: 6600466
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evidence that bovine conglutinin reacts with an early product of C3b degradation, and an improved conglutination assay.
    Linscott WD; Ranken R; Triglia RP
    J Immunol; 1978 Aug; 121(2):658-64. PubMed ID: 98586
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interaction of target cell-bound C3bi and C3d with human lymphocyte receptors. Enhancement of antibody-mediated cellular cytotoxicity.
    Perlmann H; Perlmann P; Schreiber RD; Müller-Eberhard HJ
    J Exp Med; 1981 Jun; 153(6):1592-603. PubMed ID: 7252421
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Factors influencing the endocytosis of immune complexes.
    van Es LA; Daha MR
    Adv Nephrol Necker Hosp; 1984; 13():341-67. PubMed ID: 6236677
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Complement receptor lymphocytes in the rabbit I. an SIg-negative subpopulation in the appendix.
    Green WR; Fanger MW
    J Immunol; 1976 Nov; 117(5 Pt.2):1805-11. PubMed ID: 993581
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characterization of C3-binding proteins on mouse neutrophils and platelets.
    Quigg RJ; Alexander JJ; Lo CF; Lim A; He C; Holers VM
    J Immunol; 1997 Sep; 159(5):2438-44. PubMed ID: 9278336
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Subpopulations of human lymphocytes differing in receptors to mouse and sheep red blood cells.
    Kunicka J; Matej H
    Arch Immunol Ther Exp (Warsz); 1983; 31(4):409-16. PubMed ID: 6367695
    [TBL] [Abstract][Full Text] [Related]  

  • 32. IgM complex receptors on subpopulations of murine lymphocytes.
    Lamon EW; Andersson B; Whitten HD; Hurst MM; Ghanta V
    J Immunol; 1976 May; 116(5):1199-1203. PubMed ID: 1083866
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characteristics of isolated erythrocyte complement receptor type one (CR1, C4b-C3b receptor) and CR1-specific antibodies.
    Dobson NJ; Lambris JD; Ross GD
    J Immunol; 1981 Feb; 126(2):693-8. PubMed ID: 7005341
    [No Abstract]   [Full Text] [Related]  

  • 34. Studies on the in vivo effects of antibody. Interaction of IgM antibody and complement in the immune clearance and destruction of erythrocytes in man.
    Atkinson JP; Frank MM
    J Clin Invest; 1974 Aug; 54(2):339-48. PubMed ID: 4847248
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of antibody and complement in the immune clearance and destruction of erythrocytes. II. Molecular nature of IgG and IgM complement-fixing sites and effects of their interaction with serum.
    Schreiber AD; Frank MM
    J Clin Invest; 1972 Mar; 51(3):583-9. PubMed ID: 4622104
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Comparative studies of Fc receptors for IgG on resting and activated mouse T lymphocytes using different methods].
    Hückel C; Sandor M; Erdei A; Jensen HL; Brock J; Rychly J; Gergely J
    Allerg Immunol (Leipz); 1986; 32(1):47-56. PubMed ID: 2940850
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Complement receptor expression by neoplastic and normal human cells.
    Gaither TA; Magrath IT; Berger M; Hammer CH; Novikovs L; Santaella M; Frank MM
    J Immunol; 1983 Aug; 131(2):899-905. PubMed ID: 6306108
    [TBL] [Abstract][Full Text] [Related]  

  • 38. C3-mediated cytoadherence. II. Dependence of cell attachment on similar topographic distribution of the receptors (for C3) and the ligands (C3/C3b).
    Landen B; Strunkheide K; Dierich MP
    J Immunol; 1978 Dec; 121(6):2539-41. PubMed ID: 102696
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Assay of membrane complement receptors (CR1 and CR2) with C3b- and C3d-coated fluorescent microspheres.
    Lambris JD; Ross GD
    J Immunol; 1982 Jan; 128(1):186-9. PubMed ID: 7033372
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Complement inhibitor(s) released by leukocytes. I. Pretreatment of sheep erythrocytes with supernatants of mouse spleen and thymus cells inhibit whole complement activity and C2 utilization.
    Bernard A; Boumsell L; Borsos T; Good RA; Day NK
    J Immunol; 1975 Oct; 115(4):1087-90. PubMed ID: 1176766
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.